# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001485003-21-000213
Filing Date
2021-11-01
Accepted
2021-11-01 08:00:17
Documents
16
Period of Report
2021-11-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | sesn-20211101.htm iXBRL | 8-K | 40333
2 | EX-99.1 | cmctypeameetingoutcomesv.htm | EX-99.1 | 11889
6 | GRAPHIC | cmctypeameetingoutcomesv001.jpg | GRAPHIC | 286531
7 | GRAPHIC | cmctypeameetingoutcomesv002.jpg | GRAPHIC | 308699
8 | GRAPHIC | cmctypeameetingoutcomesv003.jpg | GRAPHIC | 280629
| Complete submission text file | 0001485003-21-000213.txt |  | 1405272

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sesn-20211101.xsd | EX-101.SCH | 1914
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sesn-20211101_lab.xml | EX-101.LAB | 24993
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sesn-20211101_pre.xml | EX-101.PRE | 13190
9 | EXTRACTED XBRL INSTANCE DOCUMENT | sesn-20211101_htm.xml | XML | 11816

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 211365337
SIC: 2834 Pharmaceutical Preparations